Skip to main
AVTR

Avantor Inc. (AVTR) Stock Forecast & Price Target

Avantor Inc. (AVTR) Analyst Ratings

Based on 14 analyst ratings
Hold
Strong Buy 0%
Buy 21%
Hold 57%
Sell 21%
Strong Sell 0%

Bulls say

Avantor is a global provider of products and services to the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. They have a diverse product portfolio and a global footprint with over 300,000 customer locations in more than 180 countries. Despite facing headwinds from some of its product groups, management's turnaround efforts have shown positive results, leading to an increased target price from $8 to $15. However, there is still work to be done to fully realize Avantor's potential and investors should carefully monitor the company's execution and its ability to grow closer to bioprocess company growth rates.

Bears say

Avantor is undergoing a management turnaround, but the company still faces struggles in the near term due to customer funding uncertainty in academic and government markets, as well as competition in the biotech end market. While the company has made efforts to improve its operations, there are concerns around execution and a slower return to growth. Additionally, the company's valuation reflects a lower growth outlook and there is risk that end market recovery may take longer than expected.

Avantor Inc. (AVTR) has been analyzed by 14 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 21% recommend Buy, 57% suggest Holding, 21% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Avantor Inc. and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Avantor Inc. (AVTR) Forecast

Analysts have given Avantor Inc. (AVTR) a Hold based on their latest research and market trends.

According to 14 analysts, Avantor Inc. (AVTR) has a Hold consensus rating as of Aug 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12.54, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12.54, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Avantor Inc. (AVTR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.